Europe Embolization Devices Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis

The Europe embolization devices market size is expected to reach US$ 1,671.99 million by 2031 from US$ 886.97 million in 2024. The market is estimated to record a CAGR of 9.6% from 2025 to 2031.

Executive Summary and Europe Embolization Devices Market Analysis:

The Europe embolization devices market is further segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region occupies a significant position in the overall market and is expected to record a strong growth rate during the forecast period. The market growth in the region is mainly attributed to the burgeoning cases of colorectal cancer and gastrointestinal bleeding.

Europe Embolization Devices Market Strategic Insights

Get more information on this report Request Free Sample PDF

Europe Embolization Devices Market Segmentation Analysis

Key segments that contributed to the derivation of the Europe embolization devices market analysis are type, application, and end user.

• Based on type, the Europe embolization devices market is segmented into embolization coils, plugs, beads, glues, and others. The embolization coils held the largest share of the market in 2024. The embolization coils segment is further sub segmented into central application and peripheral application.
• Based on application, the Europe embolization devices market is segmented into neurology, peripheral vascular disease, oncology, urology, and others. The neurology held the largest share of the market in 2024.
• Based on end user, the Europe embolization devices market is segmented into hospitals, ambulatory centers, and others. The hospitals held the largest share of the market in 2024.

Europe Embolization Devices Market Outlook

Small and big companies operating in the embolization devices market are increasingly adopting strategies such as geographic expansions, new product developments, and technological advancements to boost their revenues. A few of the noteworthy product developments and approvals in the embolization devices market, which are expected to drive its growth in the coming years, are mentioned below.

• In January 2024, the National Medical Products Administration provided marketing approval for the ZYLOX Phoenix Peripheral Detachable Fibered Coil Embolization System manufactured by Zylox-Tonbridge Medical Technology Co Ltd. ZYLOX Phoenix is an innovative, proprietary medical device designed for the minimally invasive interventional treatment of peripheral arterial embolism. Peripheral vascular intervention is the most prevalent application of this embolization coil system. Embolization treatment of visceral aneurysms, and the endoleak management of abdominal aortic aneurysms, hemoptysis, and arteriovenous fistula are the other important clinical applications of the system. With the regulatory approval for the use in these applications, the system has received international recognition for its safety and efficacy.
• In October 2023, Sirtex Medical announced the commercial launch of the Lava Liquid Embolic System (LES), approved for the treatment of peripheral vascular hemorrhage. According to the company, Lava offers customizable volume and viscosity options to enable precise and controlled occlusion of target vessels. Available in 2-mL and 6-mL configurations, the system is specifically optimized for use in the peripheral vasculature. Its range of viscosities allows for effective distal embolization, reaching small and otherwise inaccessible vessels where other embolic agents may be less effective.

Therefore, new product developments and marketing approvals are anticipated to create lucrative growth opportunities in the embolization devices market.

Europe Embolization Devices Market Country Insights

Based on country, the Europe embolization devices market comprises Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany held the largest share in 2024.

The embolization devices market growth in Germany is driven by a strong healthcare system, significant investments in medical research, and the early adoption of minimally invasive technologies. According to GLOBOCAN 2022, Germany recorded ~62,544 new colorectal cases (including 29,347 women and 33,197 men) in 2022; nearly 1 in 8 of these cases show cancerous growth in the large intestine (colon) or rectum in clinical evaluation. Hospitals and clinics in the country are well-equipped with interventional radiology departments that frequently utilize embolization techniques for treating conditions such as aneurysms, arteriovenous malformations, and tumors. The healthcare sector in the country also benefits from a well-organized reimbursement framework that supports the use of innovative procedures, encouraging the adoption of embolization therapies on a broader scale.

Germany is home to leading academic institutions and research centers that partner with global MedTech companies to develop and refine embolization technologies. For instance, a research team from Charité – University Hospital Berlin was awarded the RSNA 2024 Trainee Research Prize for their retrospective, single-center study involving 403 patients aged 40–90 (median age 69) with moderate to severe knee osteoarthritis who underwent genicular artery embolization (GAE). The study assessed the safety and effectiveness of this novel interventional procedure for managing symptoms associated with knee osteoarthritis. Radiology departments in Germany also have well-established training and certification programs for interventional radiologists in place, ensuring high procedural quality and patient outcomes. There is also a growing trend toward using embolization in oncology, particularly for treating liver and uterine cancers, due to its targeted approach and lower risk profile compared to surgery.

Europe Embolization Devices Market Report Highlights

Europe Embolization Devices Market Company Profiles

Some of the key players operating in the market include Medtronic Plc; Cook Medical Holdings LLC; Stryker Corp; Boston Scientific Corp; Terumo Corp; Johnson & Johnson; Abbott Laboratories; NeuroSafe Medical Co. Ltd; Wallaby Medical; Sirtex Medical Ltd; GEM srl; Penumbra Inc.; Balt; Lepu Medical Technology Beijing Co Ltd; INVAMED; Meril Life Sciences Pvt Ltd; Merit Medical Systems Inc; and Lifetech Scientific Corp, among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Europe Embolization Devices Market Research Methodology :

The following methodology has been followed for the collection and analysis of data presented in this report:

• Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations.
• Industry trade journals and other relevant publications.
• Government documents, statistical databases, and market reports.
• News articles, press releases, and webcasts specific to companies operating in the market.

Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.

• Primary Research

The Insights Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research.
• Enhance the expertise and market understanding of the analysis team.
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects.

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

Europe Embolization Devices Market Country and Regional Insights